Semi Lim
Impact in
-
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Genomics, phytochemicals, and oxidative stress
- Histone Deacetylase Inhibitors Research
- RNA and protein synthesis mechanisms
Papers in
-
- Ubiquitin and proteasome pathways 4
- Heat shock proteins research 3
- Natural product bioactivities and synthesis 2
- Oncology 5
- Peptidase Inhibition and Analysis 4
- Co-authors
- Ki Won Lee (6 shared papers)Sanguine Byun (5 shared papers)Lee Farrand (4 shared papers)Zigang Dong (4 shared papers)Hyong Joo Lee (3 shared papers)Sung‐Hoon Kim (8 shared papers)Dae Gyu Kim (7 shared papers)Ann M. Bode (2 shared papers)
- Journals
- Journal of Biological Chemistry (2 papers)Journal of Medicinal Chemistry (2 papers)Cancer Research (2 papers)Clinical Cancer Research (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- South KoreaUnited StatesCanada
In The Last Decade
Semi Lim
14 papers receiving 472 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 351
- Cancer Research 62
- Geriatrics and Gerontology 16
- Biochemistry 23
- Pharmacology 31
Countries citing papers authored by Semi Lim
This map shows the geographic impact of Semi Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Semi Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Semi Lim more than expected).
Fields of papers citing papers by Semi Lim
This network shows the impact of papers produced by Semi Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Semi Lim. The network helps show where Semi Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Semi Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 110 | |
| 2 | 2013 | 86 | |
| 3 | 2012 | 68 | |
| 4 | 2016 | 43 | |
| 5 | 2013 | 38 | |
| 6 | 2019 | 38 | |
| 7 | 2019 | 27 | |
| 8 | 2020 | 19 | |
| 9 | 2015 | 14 | |
| 10 | 2015 | 14 | |
| 11 | 2020 | 12 | |
| 12 | 2020 | 7 | |
| 13 | 2021 | 3 | |
| 14 | 2021 | 1 | |
| 15 | 2020 | 0 | |
| 16 | 2019 | 0 | |
| 17 | 2024 | 0 | |
| 18 | 2022 | 0 |
About Semi Lim
Semi Lim is a scholar working on Molecular Biology, Oncology, Computational Theory and Mathematics, Pharmacology and Cell Biology, having authored 18 papers that have together received 480 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), Peptidase Inhibition and Analysis (4 papers), Computational Drug Discovery Methods (3 papers), Heat shock proteins research (3 papers), Natural product bioactivities and synthesis (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Synthesis and biological activity (2 papers) and Diverse Approaches in Healthcare and Education Studies (2 papers). The work is most often cited by research in Molecular Biology (351 citations), Cancer Research (62 citations), Geriatrics and Gerontology (16 citations), Biochemistry (23 citations) and Pharmacology (31 citations). Semi Lim has collaborated with scholars based in South Korea, United States and Canada. Frequent co-authors include Ki Won Lee, Sanguine Byun, Lee Farrand, Zigang Dong, Hyong Joo Lee, Sung‐Hoon Kim, Dae Gyu Kim, Ann M. Bode, Eunjung Lee and Ji‐Man Park. Their work appears in journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry, Cancer Research, Clinical Cancer Research and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.